Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

Prior to the law, Medicare paid what the drug companies ... order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits over what the ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...